alternatively delivery/execution of a sub-milestone every fortnight worth reporting on might give the dopamine fix the market needs to maintain momentum
- HREC approval
- first patient recruited
- first patient dosed
- ADOA / PYC-001 lead selected with enhanced v2 delivery/exon skipping profile
the above to follow on from the Mar 6th announcement will keep the momentum going.
Not asking for hype, but steady timely progress updates will help investors understand when they click on our ticket and glance at our ASX announcement headers. Will be great if they tune into our investor call, but that’s a dime a dozen.
Ann: FDA Clears PYC to Commence First Human Trials in RP11, page-77
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.020(11.1%) |
Mkt cap ! $933.2M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 20.5¢ | 18.0¢ | $1.219M | 6.294M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 106194 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 184767 | 1 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| PYC (ASX) Chart |